- CytRx Corporation CYTR shares touched a new 52-week low of $0.769 after the company reported initial results of Phase 3 trial of aldoxorubicin in patients with second-line soft tissue sarcoma.
- T2 Biosystems Inc TTOO shares touched a new 52-week low of $5.06. T2 Biosystems shares have dipped 69.08 percent over the past 52 weeks, while the S&P 500 index has gained 1.79 percent in the same period.
- Real Goods Solar, Inc. - Class A RGSE shares fell 8.99 percent to touch a new 52-week low of $3.44. Real Goods Solar shares have tumbled 88.40 percent over the past 52 weeks, while the S&P 500 index has gained 1.79 percent in the same period.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in